Shimiao Zhu, Changyi Quan, Haotian Wei. "Neoadjuvant lenvatinib plus pembrolizumab for resectable clear-cell renal cell carcinoma (PELUR): A prospective phase 2 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4541